Activation of the integrated stress response by the developmental HSF1 pathway inhibitor NXP800

被引：0
|
作者：
Powers, Marissa V.
Sharp, Swee Y.
Lampraki, Eirini-Maria
Roe, Toby
Pellegrino, Loredana
Taskinen, Maria
Poele, Robert Te
Raynaud, Florence
Eccles, Suzanne
Cheeseman, Matthew
Jones, Keith
Clarke, Paul A.
Workman, Paul
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 08期
关键词：
D O I：
10.1158/1538-7445.AM2023-LB234
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
LB234
引用
收藏
页数：3
相关论文
共 50 条
  • [1] NXP800: A first-in-class orally active, small-molecule HSF1 pathway inhibitor
    Workman, Paul
    CANCER RESEARCH, 2022, 82 (12)
  • [2] Discovery of ARID1A loss as a patient biomarker for NXP800-A developmental activator of the integrated stress response (ISR) and inhibitor of the HSF1 pathway in ovarian cancer
    te Poele, Robert H.
    Powers, Marissa
    Sharp, Swee
    de Billy, Emmanuel
    Taskinen, Maria
    Pellegrino, Loredana
    Gowan, Sharon
    Miah, Asadh
    Hayes, Angela
    Cheeseman, Matthew
    Jones, Keith
    Eccles, Suzanne
    Raynaud, Florence
    Clarke, Paul
    Workman, Paul
    CANCER RESEARCH, 2024, 84 (06)
  • [3] Discovery and validation of biomarkers to support clinical development of NXP800: A first-in-class orally active, small-molecule HSF1 pathway inhibitor
    Workman, P.
    Clarke, P. A.
    Poele, R. Te
    Powers, M.
    Box, G.
    De Billy, E.
    Brandon, A. De Haven
    Hallsworth, A.
    Hayes, A.
    McCann, H.
    Sharp, S.
    Valenti, M.
    Raynaud, F. I.
    Eccles, S. A.
    Cheeseman, M.
    Jones, K.
    EUROPEAN JOURNAL OF CANCER, 2022, 174 : S35 - S35
  • [4] HSF1 Pathway Inhibitor Clinical Candidate (CCT361814/NXP800) Developed from a Phenotypic Screen as a Potential Treatment for Refractory Ovarian Cancer and Other Malignancies
    Pasqua, A. Elisa
    Sharp, Swee Y.
    Chessum, Nicola E. A.
    Hayes, Angela
    Pellegrino, Loredana
    Tucker, Michael J.
    Miah, Asadh
    Wilding, Birgit
    Evans, Lindsay E.
    Rye, Carl S.
    Mok, N. Yi
    Liu, Manjuan
    Henley, Alan T.
    Gowan, Sharon
    De Billy, Emmanuel
    te Poele, Robert
    Powers, Marissa
    Eccles, Suzanne A.
    Clarke, Paul A.
    Raynaud, Florence I.
    Workman, Paul
    Jones, Keith
    Cheeseman, Matthew D.
    JOURNAL OF MEDICINAL CHEMISTRY, 2023, 66 (08) : 5907 - 5936
  • [5] Activation of the integrated stress response by NXP800, an orally available, clinical-stage, investigational agent in ARID1A-mutated, platinum resistant ovarian cancer
    Powers, Marissa V.
    Swap, Swee Y.
    te Poele, Robert
    Lampraki, Eirini-Maria
    Roe, Toby
    Pellegrino, Loredana
    Taskinen, Maria
    Eccles, Suzenne
    Raynaud, Florence
    Cheeseman, Matthew
    Jones, Keith
    Clarke, Paul A.
    Workman, Paul
    CANCER RESEARCH, 2024, 84 (05)
  • [6] Identification of small molecule inhibitors of HSF1 stress pathway activation in cancer cells
    de Billy, Emmanuel
    Chessum, Nicola
    Te Poele, Robert
    Smith, Jennifer
    Zani, Lorenzo
    Sharp, Swee
    Stubbs, Mark
    Aherne, Wynne
    Jones, Keith
    Workman, Paul
    CANCER RESEARCH, 2014, 74 (19)
  • [7] From targeted phenotypic screen to NXP800: A clinical stage activator of the integrated stress response for the treatment of ARID1A-mutated ovarian carcinoma
    Workman, Paul
    MOLECULAR CANCER THERAPEUTICS, 2023, 22 (12)
  • [8] HSF1 mediated stress response of heavy metals
    Steurer, Christoph
    Eder, Noreen
    Kerschbaum, Sarah
    Wegrostek, Christina
    Gabrie, Stefan
    Pardo, Natalia
    Ortner, Viktoria
    Czerny, Thomas
    Riegel, Elisabeth
    PLOS ONE, 2018, 13 (12):
  • [9] Bis is Induced by Oxidative Stress via Activation of HSF1
    Yoo, Hyung Jae
    Im, Chang-Nim
    Youn, Dong-Ye
    Yun, Hye Hyeon
    Lee, Jeong-Hwa
    KOREAN JOURNAL OF PHYSIOLOGY & PHARMACOLOGY, 2014, 18 (05): : 403 - 409
  • [10] Optimal HSF1 activation in response to acute cold stress in BAT requires nuclear TXNIP
    Waldhart, Althea N.
    Lau, Kin H.
    Dykstra, Holly
    Avequin, Tracey
    Wu, Ning
    ISCIENCE, 2023, 26 (05)
12345